Development of chimaeric West Nile virus attenuated vaccine candidate based on the Japanese encephalitis vaccine strain SA14-14-2
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of chimaeric West Nile virus attenuated vaccine candidate based on the Japanese encephalitis vaccine strain SA14-14-2
Authors
Keywords
-
Journal
JOURNAL OF GENERAL VIROLOGY
Volume 94, Issue Pt_12, Pages 2700-2709
Publisher
Microbiology Society
Online
2013-10-04
DOI
10.1099/vir.0.059436-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A single nucleotide mutation in NS2A of Japanese encephalitis-live vaccine virus (SA14-14-2) ablates NS1' formation and contributes to attenuation
- (2012) Q. Ye et al. JOURNAL OF GENERAL VIROLOGY
- Repeated In Vivo Stimulation of T and B Cell Responses in Old Mice Generates Protective Immunity against Lethal West Nile Virus Encephalitis
- (2011) Jennifer L. Uhrlaub et al. JOURNAL OF IMMUNOLOGY
- A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial
- (2011) Julie E. Ledgerwood et al. JOURNAL OF INFECTIOUS DISEASES
- A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein
- (2011) Yong-Qiang Deng et al. PLoS One
- A Recombinant Influenza A Virus Expressing Domain III of West Nile Virus Induces Protective Immune Responses against Influenza and West Nile Virus
- (2011) Byron E. E. Martina et al. PLoS One
- Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease
- (2011) Julio Alonso-Padilla et al. VACCINE
- Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Immunogenicity and Safety of a West Nile Virus Vaccine in Healthy Adults
- (2010) Rex Biedenbender et al. JOURNAL OF INFECTIOUS DISEASES
- Nanopatch-Targeted Skin Vaccination against West Nile Virus and Chikungunya Virus in Mice
- (2010) Tarl W. Prow et al. Small
- Development and evaluation of a formalin-inactivated West Nile Virus vaccine (WN-VAX) for a human vaccine candidate
- (2010) Guillermo Posadas-Herrera et al. VACCINE
- Immunogenicity of RepliVAX WN, a novel single-cycle West Nile virus vaccine
- (2010) Michelle H. Nelson et al. VACCINE
- Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities
- (2010) Yongxin Yu VACCINE
- Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine in Rhesus Monkeys
- (2009) M. M. Lieberman et al. Clinical and Vaccine Immunology
- RNA elements within the 5' untranslated region of the West Nile virus genome are critical for RNA synthesis and virus replication
- (2009) X. F. Li et al. JOURNAL OF GENERAL VIROLOGY
- Effectiveness of One Dose of SA 14-14-2 Vaccine against Japanese Encephalitis
- (2009) Rashmi Kumar et al. NEW ENGLAND JOURNAL OF MEDICINE
- RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters
- (2009) Douglas G. Widman et al. VACCINE
- Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus
- (2008) David C Chang et al. NATURE BIOTECHNOLOGY
- Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine
- (2008) Frédéric Coutant et al. PLoS One
- Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants
- (2008) Salvacion Gatchalian et al. VACCINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now